Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | KLK1 | P06870 | 1/20 | 0.32 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.32 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6598418 | 0.99 | KMT2A (0.36) | KMT2AMAPK8ROCK2APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL1194131 | 0.98 | KMT2A (0.35) | KMT2AMAPK8ROCK2APOBEC3AAPOBEC3G | |
| Hydrochloric Acid SCHEMBL1194126 | 0.88 | MAPK8 (0.38) | KMT2AMAPK8ROCK2APOBEC3AAPOBEC3G | |
| SCHEMBL6597480 | 0.87 | MAPK8 (0.39) | KMT2AMAPK8ROCK2APOBEC3AAPOBEC3G | |
| Hydrochloric Acid SCHEMBL1195003 | 0.84 | CYP3A4 (0.39) | KMT2AMAPK8APOBEC3AAPOBEC3GCYP3A4 | |
| Hydrochloric Acid SCHEMBL1194038 | 0.84 | LMNA (0.42) | KMT2AAPOBEC3AAPOBEC3GCYP2D6HTT | |
| SCHEMBL6599056 | 0.83 | CYP3A4 (0.39) | KMT2AMAPK8APOBEC3AAPOBEC3GCYP3A4 | |
| SCHEMBL6597741 | 0.83 | LMNA (0.41) | KMT2AAPOBEC3AAPOBEC3GCYP2D6HTT | |
| Hydrochloric Acid SCHEMBL5358894 | 0.81 | MEN1 (0.38) | KMT2AMAPK8ROCK2HTTHPGD | |
| SCHEMBL6598655 | 0.80 | MEN1 (0.38) | KMT2AMAPK8HTTHPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7223777-B2 | Compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof | TORRENT PHARMACEUTICALS LTD. (IN) | 2007-05-29 | — | — | US | claimed |